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Chapter 11
Immune responses to pneumococcal polpaccharides (PPS) derived from the capsule of
Strqtw.s show a completely different response pattern compared to protein antigens.
Ig}vI * well as IgG antibodies are rapidly induced but also decline quite fast [1-6]. The nature of
the induced memory is still a m).ctery as secondary ftoost) vaccination does not lead to increased
antibodylevels [6], but clinical protection does seem to be obtained U;7;8]. Oassical IgG switched
memory cells are not induced but longeviry of antibodies is thought to compensate for these cells
[9J. The splenic marginal zone has been shown to play a vital role in the rapid response against
polpaccharide antigens [10-14]. Children below the age of 2 yars and patients receiving
chemotherapy show a reduced anti-polpaccharide response. The explanation for this most lilaiy
is due to a non-functional marginal znrLe.
In this thesis, studies are presented, concerning the relation between the splenic margtnil, zone
and anti-PPS antibody responses in the normal situation and when affected by chemotherapy. Ve
have analszrd the development of the human spleen in relation to the immature anti-PPS
response in infants. Because chemotherapy results in an increased risk for infections caused by
StrEtma we investigated the effects of chemotherapy on B cell subpopulations like
marginal zone B cells and the consequences on anti-PPS responses. Since vaccination is a good
option to prevent infections by Strcptw.s plwnrrniae, we anal .arcd the characteristics of PPS
vaccination in comparison with PCV vaccination. Finally, we investigated whether vaccination can
be expected to contribute to a higher level of protection against infection wrth Streptms
prumontae during and directly aÍter chemotherapy.
The splenic marginal zone
The splenic marginal zone is a unique companment, in its cellular and anatomical composition
only found in thi spleen ll5-t7l.Ir appears to be designed for the rapid induction of humonl
uïunune responses [14;18;19]. In chapte r 2, we extensively review the unique features thatntake
the splenic marginal zone so well equipped for rapid induction of humoral immune responses'
The key issue in the induction of rapid responses to novel blood-borne antigens is that narve B
cells can respond to antigens even 
"íth antigen receptors that are of low affiniry. the 
capablryoÍ
B cells to respond with low affwy antigen receptors enables a rapid response to abroadvanay.
of antigens ti8]. Recently it has bá"n dà-orrstr"ted that the antigen ,...ptorc of narve narpn^
zone B cell are multi-reactive l2O-221. The splenic marginal ,orr. i, located centrallyin the blooó
flow and because of the pr.r.n.. of a sinus lat le"st inlhe rat) in which the splenic-arterial bloo&
flow opens, the blood-flow is substantial reducedl23l. This enables an intimate contact hrcËo
antigens and effector cells. In addition, B cells express surface molecules lile CD21, CD81, CDl9
and Leu-13 that enable a lowering of the threshold for activation114;24-261. N thesefeamra
(multi-reactiviry and lowering of tËeshold for activation in combination with ih. lo* blood'flod
make splenic marginal zone"B cells one of the fint cells to come in close contact wfuh novd
blood-borne antigens, capable of responding to these antigens. Marginal zoneB celis expresshif
levels of surface CI.2I;221, u'hich is able to crosslink with surfa.. IgM and facilitates the bidi[
of complement-opso ntzÊd a.rtigens, especially C3d opsonized capsJat PPS [28-30]. The capdr
polpac.h"rid" 
".rtig..rr of .rráprnl"tËd bacieria "r" so-call"d f ceil independeni W 2 $ry
"ntig".rr 
and fail to stimulate MHC class II dependent T-cell help [3 L;32], indicating tIfi efu
mechanism is involved in the response to ï-2 antigens. The splenic marginalzoneproviCcl
opdmal microenvirorunent for rapid responses toTI-2 polpaccharide antigens.
Antigen specific B cells are induced to proliferate already within the fint day of gt
immunization wrth ï-2 antigens [33]. In T cell dependent (ID) responses, an intervaloÍ
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rl  a ]  
h'""gi'J;J"ïÏ:' [al ;a s]' In chapr.by staining rhe maryin
F'ing step in - tï-o:"-tes [33;34]. Initiation of rapid responses to Tr-2antigens is confined to
ffi,::'.ï,:l :::r,^t^"-1 .l.J activated, f-;.ri''ï; 
"., 
have ro be in a soeciric snro-i.
Summary, neral discussion, and pers
ffiï.m;ru;'""""ut3ïï,ïr*'i"""r";;;;;?",ffii:hï,ï#ïïïffi:Jr".:*:
rpment of the spleen
il::tï":ï: :i: :j,,3^.l.iT h1,.,. ,-pature immune response characteristiailv polpaccharide.antig.r,r, 
-ort iJ..ry b.l"*. ;i-#,--::ïï;,ilÍ.'iï'ff&:tïïJr analSznd the developm"ent of the i"f*, spleen.
f; ir:rui ïiïn;*j* m:*#j::lïT.*i, * :5ï :-ra.men6 or,herursrr rravc completecl the' mat'ration to an adult ,w. i^""lfi."oqzpe and
ïfH,:ï.j# lï:::11;;; r* ïr,. ï"re_a zone rizt.rhe maincteristics of the infant lvz' wasthe lowo, 
"brËnt;;p,*Ï",iffiti?ia':ï#Ïr*HB cells [12]. Because the hrr-or"l 
..srionrl -*eiJ;; wirh hioh .-^--..-]::':rt::i:?:S:l'1]::!'d1.". higl,lvd.p."d;;;;;;narmargtt'o":,*l1qÈi*,í.ïïr'6;ïiiËïï,ï;;;::ifoï,ïf ïI ji:f#::ï;are defective in initiat-g á" 
"d.q,r"r. response to capsular polpaccharides derived from,sulated bacteria [Z;g;1 Zfrï]. 
--1---
e marginal znne of the human adult contains mostly memory B cells. This was demonstratedÏrilïïïin*.irffi :ffiï:*t/-i1,1'::í.1;ïií'"''rï",;;^in,hevhgenee a hallrnark or memoryB ..1' r+zj *l;J*". ffi*ïï+: tïËif,ïï::",ï.ir;lï i:i:ï
'r11;;:-ir'im*i,':i:i1';i: *r:.-:l--Jdryij,n. presence or memoryB ceus inthemarginal zone bv staining th. -"rsi,r"r r;;-B :;rË#rïï::ï:Tffiri."*:,*:
microenvirorunent in orde.o-..'*r..lt.cpte 
- ËË/ X::u"..,f ,*1, f,"ji::ïï-.'ftffrantigens, migrate to the ourer pari probábly È;;il;r? ,r,. 
"..áÍ., T.cell derived ficËrs t331.Large clusters of antigen-specific uttr,,are mo-stlyseen in th. orrt..PALS and in e>rtra-folricurarfoci rn the red pulp aieas ád)".".r, à p T *lË;'J:r,rr1 *d 
"r. 
m-osr rikry responsible forthe production of massive alnounts of neutral;irrg *iiuodiËs h ;;;L phase of infection. Inaddition' some activated ^ ^'g^Á tone B ..lh *fil iqf* to the,germinal cenrer, initiating agennnal center process but be"cause of lack 
"r 
àir.o 'i..[ contact, these germinal center win not
nj*.,t:l "iltne, rrc r*it.h.d À.moryB cells [36;32].
.tn: I1-2 re:P-onse is characterbnd by.a rapid, i"d;.;"- 
"{.IgM antibodies concuÍrent with thenductron of IgG antibodies. Normally, fá, j:;,rn-.- r*,.h-ï;f ;"-*ral center B cells, thePresence of immunecomplexes is ,q.rire d yr+1'.'Thrr.. 
.rrrrr,ri.rrr.9;;;1.ï.s are composed ofspecific antibodies 
"nd atttigt"' Beca*" 9f t!. i*iJ"a1uctr.ol of IgG riters, the switching ofplpaccharide specific t"tiïoái.r- 
-*, b" ;dó;dent of immunecomplexes with specificutmunoglobulins beca'se at this time poinr. ,p..'irif- i-rn rrroglobuliru- 
"r. 
,ro, yet present. Inchapter 2 we argued that this rapid ilài" fyl.hirg is iacilitatea uy,rr. rrrgn expression of azton marginal zone B cells in combination 
-ïth l";;i;;;i il"it,;ilil iï, 
".,i,ortion and murti_reactiviry' \ve prooose that 
"ft., th. first contac,, *-"1 .-rtive affrniry Lrt*"tio., and isoq,pe
:ii$JêT,*h:.;tl.'1":::"tl rJ r":ï,?ïËï: *q comprexes rocarized on germinar
ffes
center FDC's without the pr.r".'.. t:É;ld il,;,,l;.ï"ffi:ïr":'iffff",n'X,1induction of IgG switched 
"",ïu"Í.r.'Th" ódil;; IgGïs 
"r. 
-àr, ,i",r of only low affrnirybut B cells with hieher aÍfo'q'P b. generated following funher antigenic conracr.ïhe marginal ,oná aPpears to be 
" 
.J-p*mgnr,o,*lry-.l.di;;;;J;;"rpd humoral responses ro(blood-bome) antigeru' Because of ir'.'rf.lf;" ;'[rË, Ë ,h. :;;iJo"sition in the bloodstream' mareinal zone B cells are crucial in th. f^;L";à.f.;r.;;,í;;lï.,u.",ening infectioru
# *Íf ,ïï:i. *; yfï1:"1* _{ÍËï.' . o_pr.,,," "1.c3 4 as a c o mp o ne nr or the
L4T
Chapter 11
In infant spleeru below the age of 2 years, because of the absence of QZZ expression, the
maqginal znne B cells are supposed to be of naive phenor;pe [46]. Berween the age of 2 to 5 years,
the number of C|27 positive B cells increased to adult numbers around 5 years of age. The
increasing number of memory B cells in the marginal zone most likely is driven by ongoing
antigenic stimulation.
Ve speculate that the immaturiry of the humoral anti-polpaccharide response in infants below
the age of rwo years may have its effect on induction of the humoral response as well as
formation of memory. It seems that the infant spleen is fully matured and functional at 2 yars o[
age and that memoryB cells are capable of entering the marginaJ. zone at this time point.
Evolutionary benefit because of the absent CD21 e xprcssion in early life?
Is there an evolutionary benefit of the absence of @21 expression in the marginal zone of an
infant below the age of 2 yas? In the literature, there are some indications that the naive
marginal zone B cells are involved in autoreactiviry and the induction of tolerance lL4;47-491.
Chen et al. demonstrated that autoreactive B cells in 'B cell activation factor from the TM
family' (BAFF) transgenic mice can colonize the marginal znne 1201. BAFF can prevent
autoreactive B cells from going into apoptosis [50]. In BAFF transgenic mice, immature
autoreactive B cells can be rescued by BAFF from negative selection. The mature autoreactive B
cells skewed towards the marginal zone compaftment 1471. Fur.ther, Fagarasan and Honjo have
constructed a model for regulation of the autoreactive B cell response [51]. \X4ren autoreactive B
cells accidentally become activated, this signal is most often suboptimal because of weak cross-
reactiviry absence of opsonization or limited amounts of stimulants. This suboptimal signal will
induce PD- 1 expression. These PD- 1 positive B cells can survive and enter the circulation. The
iigand of PD- 1 is expressed on various organs and ligation of PD- 1 results in the suppression and
elimination of activated autoreactive B cells, preventing activation of autoreactive B cells in the
periphery [51].
The absence of CD21 expression on marginal zone B cells may be necessary to prevent
autoreactive marginal zone B cells from reacting easily to autoantigens with subsequent
díferentiation to antibody secreting plasma cells. This mechanism of preventing marginaJznneB
cells to react to autoantigens may be essential to allow clearing of self-antigens from t}re
circuiation and induction of tolerance in an early period of life despite the fact that this is at cost
of an increased risk for blood-borne infections.
Functional aspects of anti-polysaccharide responses in the immunocompÍomised host
Suppression of the immune s)6tem in children with malignant diseases is a main problenl52-541.
The cause of suppression is mostly twofold, on one hand by the immune de-regulation as a
consequence of the disease and on the other hand by the use of chemotherapeutic agentr.
Infections with encapsulated bacteria appear to be responsible for a higher morbidiry and
mortaliry in patients treated with chemotherapy 154-561. The neutropenic and granulocytopenic
effects of chemotherapy are best known but also the lymphoid slstem can be heavily affeaed.
Initially we loolcd at the effects of a single dose of a single cytostatic agent on B cell
subpopulations in the spleen, blood, and bone marrow (chapter a). We used the cytostatic agents
cplophosphamide, cisplatin, and methotrexate because these agents are known for affecting the
humoral immune s)6tem 157-601. Rats were treated with a single dose of a single cytostatic aged
and sacriliced at different time points after treatment. 'We demonstrated that especiallythe nprdly
dividing immature celis were higl,ly sensitive to the tested cytostatic agents dteoJy afur
treatment. The mature B cell populations appeared to be relatively unaffected. Analyzing dr B
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cell populations at a relative long period aÍrcr chemotherapy revealed that the immature B cell
populations were recovered but the mature B cell populations were substantial reduced compared
to non-treated animals. In the long nrn, especially the marginal zone B cell population was
affected by chemotherapy. We did not find severe effects on other cell populations like T cells,
macrophages, and monocytes.
Subsequendy, in chapter 5 we anal4d the effects of a reduced marginaJ, zane population on rhe
i c.apacrry of rats to,initiate an immune response to PPS by challengpS with an:igen: at differenttime points after chemotherapy. Chemotherapy was similar to the therapy used in chapter 4. We
used two vaccines, the PPS vaccine Pneumovaxt ffl-2 antigens), and the tetanus toxoid vaccine
Tetavax@ flD antigens). Ve used vaccines as antigenic challenge to test the immune response
capaciry after chemo_tlerapy and to mimic a blood-borne bacterial infection. The immune
response capaciqy to PPS was reduced directly after chemotherapy. In contrast, the respoÍrse to
the TD antigen tetanus toxoid pggged relatively unaffected. \Vhen we anaJqd the immune
response capacity at a longer period (day 2a) after treatment, we found normal immune responses
to PPS as well as tetanus toxoid. These findings seem to be in contrast to our finding in chapter 4.
Directly after chemotherap;r, when oniy immature cells are affected and maaginal zone B cells
relative unaffected, immune responses to PPS are reduced w4rile after a certain time period, when
the marginal zone B cell population is (still) reduced, the immune response to PPS is normal.
Cytostatic agents mostly affect activated, rapidly dividing cells [58;61]. Most marginal zone B cells,
t4rich are activated by PPS, will migrate to the outer PALS and red pulp to undergo clonal
expansion [62]. During this expansion, they are possibly inhibited in thei aitiviry be.".rs. of the
cyostatic agents. At a longer period after chemotherapy when the cytostatic agents are cleared
from the circulation, the reduced number of marginal zone B cells that survived are still capable
of rutiating a response to the PPS, now without killi"g of the activated cells.
Multi-dose combination chemotherapy in the rat
In chapten 4 and 5 we used a single dose of a single agent to anaJyzn the effects of chemotherapy
on the humoral immune system. To bener match the human situation in which enensive multi-
dose combination chemotherapy is used, we designed a multi-dose combination chemotherapy
for rats based on our own experience and an exrensive literatwe study (chapter 6). This multi-
dose combination chemotherapy consisted of 4 consecutive dals of a single injection of
cyclophosphamide followed by 4 consecutive dap of a single injection of cisplatin. Similar to the
srudies in chapters 4 and 5, we fint analped the effects of multi-dose combination chemotherapy
on B cell subpopulations followed by the analpis of the immune response capacity to PPS and
tetanus toxoid. Directly after finishing therapy, B cell populations were severeiy reduced. B cell
populations appeared to be recovered after 25 dap. 'We did not find any essential effect on other
cellpopulations like T celis, macrophages, and monocytes. Directly after multi-dose combination
chemotherapy, the IgG but not the IgM response to PPS was significandy reduced compared to
control vaccinated rats. At 25 days after treatment, immune respoÍrses appeared normal again.
The unmune response to tetanus toxoid was reladve unaffected.
Data regarding the effects of chemotherapy on human splenic B cell subpopulations and immune
Íesponse capaciry are very scarce and can only be done with in ziho experiments. Human
pripheral blood lprphocyes have been used e>aeruively in stimulation e4periments with PPS
and demonstrated that it is possible to stimulate peripheral blood B lymphocytes with PPS to
induce specific antibody production [63-66]. In urro e4periments to determine the effects of
cytostatic agents have been done with human peripheral blood lprphocytes but never with
human spleen cells 167-71]. Our results obtained from the in rino expenments (chaptrr 6a)
r43
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support our animal experimental findings that especially the marginal zone B cell is vulnerable for
cytostatic agents.
From the srudies described in chapter 4, 5, 6, and 6a we conclude that immature B cell
populations are the most severe affected by chemotherapy but that these cell populations also
rapidly recovered. The mature cell population, including the margind, zone B cell population is
less directlyaffected but declines in numbers well after finishing chemotherapy. This is explained
by the fact that replenishing of the mature B cell population is delapd because of the sffong
reduction of immature progenitor B cells. The recovery of the mature B cell populations lila the
marginal zone B cells takes a substantial amount of time and extends beycnd the period of bone
rrrarrow suppressron. In human studies, only linle information is present regarding the slow
recovery of marginal znne B cells after chemotherapy and total body irradiation 172].By analpng
spleen sections of patients treated with immunosuppressive agents, it was demonstrated that the
recovery of the marginal zone was poor up to 10 months after treatment and results in a
functional asplenia for a considerable penodfZ2l.
From our results, the immune responses to TD antigens like tetanus toxoid appeared to be
relative unaffected while the pol;naccharide response showed reduced antibody titers after
chemotherapy. However, the response to PPS was not completely absent indicating that even a
few marginaJ.zone B cells are able to induce a response to PPS. Although this response is lower
compared to non-treated animals, antibody fold increases are sdll 4 times or more and it has been
shown that an antibody increase of 3 to 4 times can be considered clinically relevant [8]. Still,
patients treated with severe multi-dose combination chemotherapy are at increased risk for
infections with encapsulated bacteria, not only during but also after chemotherapy 152;54;55;73-
771. However, not only the ievel of the antibody titer is relevant for protection but also the
kinetics of antibody production in combination with the affinity of the produced antibodies is
crucial, especially in case of rapidly spreading infections by encapsulated bacteria. An additional
problem with the depletion of marginaJ. znne B cells during chemotherapy is the loss of memory
because marginal zone B cells are in human adults mostly memory cells. Memory B cells present
in the -"-rgT"l zone 
.are of. the IgM phenoqp. and slighdy activated, hence, they are most lilrely
more sensrtlve to chemotherapy compared to classical IgG switched memory B cells. The
depletion of marginal zone B cells does not only result in the reduction of a B cell population
capable of responding fast and efficient to encapsulated bacteria but also results in the loss of IgM
memoryB cells.
Immune responses to pneumococcal polysaccharide vaccine
Vaccination with PPS can prevent infections by Sneptma but the immune responses
mechanism to PPS vaccines Ne still poorly understood although vaccination is widely
recoÍrunended in risk groups like elderly and immune compromised patients. Especially the
induction of memory after vaccination with PPS is a main issue [2;7;8;28]. IgM as well as IgG
antibody titers rapidly increase to peak values after primary vaccination but also decline quite
rapidly to pre-vaccination values and classical IgG switched memory B cells are not found [79].
Vaccination with protein antigens results in a slow induction of IgG titers, which can be boosted
with a secondary vaccination to higher titers. In contrast, PPS show a complete lack of response
during secondary vaccination when humans are vaccinated within 3 to 5 pars after prrnraÍy
vaccination [4-6;80]. The absence of a secondary response has been called immune paraipis [80].
In chapterT we further analyzrd the phenomenon of immune paralpis in rats. \Jfe useddree
different doses for primaryvaccination because in mice it was demonstrated that the absence of a
secondary response is dependent on the dose used in the primaryvaccination [80-82]. In rats, we
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also found an absence of a secondary response (within the range tested) but this was independent
of the dose we used in the primaryimmunization.'When a secondaryvaccination was given at one
month after primary vaccïnation, an almost complete absence of antibody induction was
observed. At 3 to 6 months after primary vaccination, a secondary vaccination resulted in an
increase in antibody titen although titers never exceeded titers obtained in the primary
vaccination. Anallzing spleen sections of rats that received a secondary vaccination one month
after the pnmary vaccination revealed a normal localization pattern of PPS in the spleen with
additional localization of PPS in secondary follicles. This indicates that although PPS show
normai localization, activated B cells are panly "paraJTzrd" in their further activation and
production of high arnounts of antibodies. Based on a series of classical experiments by Baker
and Braley-Mullen, immune paralpis after primary vaccination most likly is due to activation of
CD8+ suppressor T cells [30-83]. The directloca\zarion of PPS in secondary follicles during
secondary vaccination could indicate that after secondary vaccination, PPS can bind residual PPS
specific antibodies generated in the primary response and that these immune complexes
subsequently immediate localize in follicles. This could indicate that although antibody levels
remain low upon secondalyvaccination, the antibodies produced are of high affiniry.
Nthough a secondary vaccine response is suppressed, primary vaccination with PPS has
empirically been demonstrated to be protective. This indicated that, although the secondary
response to the same purified polpaccharide seroqpe is suppressed, the secondary response to
the complete bacteria with the same serorype is not suppressed. Two reasons for this apparent
paradox can be postulated; fint is that the purified polpaccharide is slightly different from the
crude polpaccharide derived from the whole bacteria and that the activated suppressor T cells are
higtrly specific. Second, other components of the whole bacteria may act as a sort of natural
adjuvant or natural confugate, overruling the suppressor T cell activiry. Further research will be
necessa{y for complete elucidation [84].
Immune rcsponses to polysaccharide coniugate vaccin€
Gnjugation of PPS to proteins leads to a polpaccharide response with protein response
characteristics [85]. A pneumococcal polpaccharide conjugate vaccine PCU induces memory
similar to protein vaccination and has been demonstrated to be immunogenic in children below
the age of two )ears [39]. The major drawback of PCV is the limited number of polysaccharide-
conjugated seroqapes l7).A7-valent conjugate vaccine is registered and used and an 1.L-valent
vaccine is being developed. Flowever, the non-conjugated polysaccharide vaccine contains the 23
most prevalent serorypes and a conjugate vaccine containing 23 seroqpes will not be possible due
to protein overload [7]. FIence, the current pneumococcal poipaccharide conjugate vaccine is not
the ultimate pneumococcal vaccine. In chapten 8 and 9, we described the spleen and
complement independency of the PCV. The response to piain PPS has extensively been
demonstrated to depend on the presence of complement, especially fragment C3d [36;87]. In
complement depleted rats, no localization of PPS on marginaJ, znne B-cells was observed [38]. In
contrast, complement depletion did not impair respoÍrses to PCV and localization panerns in the
spleen were similar in complement depleted and control rats indicating that the response to the
conjugate vaccine is independent on the presence of complement and thrx likely independent of
strongly C|zl positive marginal zone B cells.
Absence of a functional spleen results in an increased risk for infections caused by encapsulated
bacteria [88;89]. The liver can paftially take over the phagocyic functions of the spleen but not
for the not or low opsonized PPS because of the higher velociry of the blood-flow through the
liver [90]. Vaccination to prevent infections should be performed at least a few weeks before
145
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splenectomy. Vaccination with PPS after splenectomy is no option because of the absence of
initiation of a response leading to antibody induction after splenectomy. The polysaccharide
conjugate vaccine in contrast, shows normal immunoge"i.iry in splenectomized rarc as would be
expected for a "protein-lile" response. So, extra-splenig lymphoid Fr.". is capable of generating a
pnrnary response to the polysaccharide conjugate vaccine. Although the primary respoÍrse to PCV
was deialed, the secondary response was similar to the secondary response in control rats. The
PCV has as an advantage that it can induce antibody response in the absence of a functional
spleen but the limited number of conjugated serorypes remains a serious problem.
In chapter 10, we examined whether vaccination before chemother^py can contribute to a higher
level of protection during or directly after chemotherapy as measured with an antigenic challenge
directly after chemotherapy. After MTX treatment, but not CyPh ffeatment, we observed
improved antibody responses similar to control vaccinated rats. PPS antigenic challenge directly
after MTX ffeatment with primaryvaccination before MTX treatment did result in antibodydten
similar to control vaccinated rats, whereas without vaccination significantly lower antibody levels
compared to control vaccinated ram are observed. This indicates that vaccination before
chemotherapy contributes to a befter resporue directly after chemotherapy. It can be conclude
that after primary vaccination, (ïfIX resistant) memory is likely induced resulting in a secondary
response, which is independent of the marginaJ.znne.
C-oncluding remarks and pers pectives
For the host, pollsaccharide-encapsulated bacteria have a major disadvantage in the induction of
a "normal" immune response because the capsular PPS caÍrnot directly activate T cells. To
circumvent this limitation, the immune response to PPS is initiated in the splenic marginal zone.
Due to several specific characteristics and features, marginal zone B cells are capable of initiating
a fast response with high quantities of neutralizing antibodies, I#Í m well as IgG, without the
necessiry of direct T cell contact. Absence of a functional spleen thus leaves the host at risk for
severe infections caused by polpaccharide- encapsulated bacteria.
Infections wtth Sneptma can be prevented byvaccination with PPS derived from the
capsule. Flowever, this can only be done in patients with a functional spleen and normal
complement s)stem. The major advantage of the pneumococcal vaccine is the broad range of
serorypes included in the vaccine. The major disadvantages are the unknown nature of the
induced memory. The recently developed PCV overcomes the splenic dependency and shows
"normal" immune response character-istic but has as major drawback the limited number of
serorypes conjugated and the higher costs.
Children below the age of 2 yars have an immature spleen and are vulnerable of infections with
Snqtrwa The marginal zone B cells of children below the age of 2 yars lack CD21
expression. This most lik ly explains the poor response of infant to PPS. Vaccination of children
below the age of 2 lean with the PPS vaccine is not warranted because of the immature spleen.
In this group, vaccination with the PCV is highly recorrunended and effective.
In the p6t, infections with .:q:.t4y. 
.e.ncapsulated bacteria cawed. problems in
immunocompromised patients. Especially Hodgkin's disease patients were at high risk for severe
infections, mostly due to splenectomy in combination with severe chemotherapy. Nowadap,
because of bener anention for infections, life-threatening infections are much less a problem
during chemotherapy. In addition, splenectomy because of staging laparotomy in case of
Hodgkin's disease is much less common. Still, infections with especially encapsulated bacteria can
be responsible for the death of a patient receiving chemotherapy, not only during chemotherapy
but also r.rntil approximately 3 )"* after chemotherapyfZ3l.
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